Two major analysts have trimmed price targets for Bank of America following its Q4 earnings, citing revised provision estimates and a pause in share repurchases, even as the bank beat profit expectations.
Despite plunging to multi-year lows, Litecoin is seeing sustained demand from payment gateways, privacy features, and long-term accumulation, suggesting a potential foundation for recovery amid a brutal market.
Dover Corporation concludes a massive $1.04 billion share repurchase while projecting measured growth for 2026, signaling a firm commitment to shareholder returns amidst ongoing earnings volatility. We analyze what this disciplined capital strategy means for investors.
Unusually high options activity signals investor focus on Match Group's upcoming earnings, as improving Tinder metrics clash with long-term share price declines and rising competition in the dating app space.
In a bid to tackle the mounting affordability crisis for first-time buyers, Santander UK has launched a 98% loan-to-value mortgage, drastically reducing the deposit required to enter the property market.
Market volatility can test even seasoned investors. We analyze two stocks with high beta that may offer substantial long-term rewards for those who can handle the swings, and flag one popular name where the risk may outweigh the potential.
The professional services firm elevates seven senior professionals to partner across key advisory divisions, a strategic move aligned with its ambitious plan to add 160 partners within two years.
AstraZeneca has entered a strategic collaboration with China's CSPC Pharmaceutical Group to co-develop and commercialize a portfolio of next-generation therapies for obesity and type 2 diabetes, significantly expanding its weight management pipeline.
Evercore ISI has upgraded Cisco Systems (CSCO) to Outperform, raising its price target to $100. The firm cites a confluence of AI momentum, a critical campus refresh cycle, and margin expansion as key drivers for sustained growth.
Walmart Inc. (WMT) is making a significant push into the health and wellness sector with major investments in pharmacy staffing and services, coinciding with a bullish price target upgrade from UBS. The retail giant's strategic moves come as competition in the pharmacy delivery space intensifies.
After a historic rally, gold and silver prices experienced a sharp correction, leaving investors questioning the drivers behind the volatility. Analysts point to shifting political winds, systemic economic anxieties, and technical market dynamics.
A partial government shutdown persists as House Republicans, holding a razor-thin majority, scramble to pass a critical spending package. The bill, funding the Pentagon and key agencies, faces fierce Democratic opposition over Immigration and Customs Enforcement (ICE) reforms, with a hard deadline of Friday the 13th looming to avert a Homeland Security funding lapse.
While robust cash generation signals corporate health, it doesn't guarantee stock market success. We analyze one company effectively deploying its cash and two where strong cash flow masks underlying risks.
UnitedHealth Group's fourth-quarter earnings call revealed a company in transition, as executives outlined strategic shifts to counter pressures in Medicare Advantage and Medicaid. The market's sharp sell-off reflects deep-seated concerns about medical cost trends and competitive dynamics.
While the S&P 500 hits new highs, not all stocks are riding the wave. We examine three well-known companies—WeightWatchers, Kyndryl, and Mobileye—that have plunged to 12-month lows, analyzing whether their declines signal a bargain or a deeper fundamental problem.
HCA Healthcare's robust Q4 performance, driven by sustained patient volume and disciplined cost management, has buoyed investor confidence. Yet, analysts' probing questions during the earnings call revealed the critical challenges and strategic pivots that will shape the hospital giant's path forward in a shifting healthcare landscape.
While Boeing's Q4 earnings surpassed expectations, driven by a surge in commercial deliveries, analysts' probing questions during the earnings call revealed the deeper challenges and uncertainties still facing the aerospace giant as it navigates production ramps, integration, and certification hurdles.
Despite meeting revenue targets, Qorvo's latest earnings drew a skeptical market response. Analysts zeroed in on the company's pivot away from low-margin smartphone business and its bets on defense and next-gen connectivity to drive future growth.
American Airlines' fourth-quarter earnings fell short of expectations, with management blaming historic disruptions from Winter Storm Fern. While revenue met targets, profit margins took a significant hit. The subsequent analyst call revealed pressing questions on the carrier's long-term strategy beyond the immediate weather impact.
RTX's strong Q4 performance, fueled by double-digit commercial growth and a soaring defense backlog, drew sharp analyst focus on execution risks and supply chain challenges during the earnings call.
